Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (17)

1

Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Susser, S. | Flinders, M. | Reesink, H. | +7

2

An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay

enthalten in: Journal of clinical microbiology | 2015

von Sarrazin, C. | Dierynck, I. | Cloherty, G. | +7

3

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region

enthalten in: Antiviral research | 2015

von Sarrazin, C. | Lathouwers, E. | Peeters, M. | +11

4

Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients : REALIZE study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2015

von Berg, T. | Andreone, P. | Pol, S. | +13

5

Low‐density lipoprotein and other predictors of response with telaprevir‐based therapy in treatment‐experienced HCV genotype 1 patients: REALIZE study

enthalten in: Liver international | 2015

von Berg, T. | Andreone, P. | Pol, S. | +13

6

Deep-sequencing analysis of the gene encoding the hepatitis C virus nonstructural 3-4A protease confirms a low prevalence of telaprevir-resistant variants at baseline and the end of the REALIZE study

enthalten in: The Journal of infectious diseases | 2014

von Dierynck, I. | Thys, K. | Ghys, A. | +5

7

Modeling viral evolutionary dynamics after telaprevir-based treatment

enthalten in: PLoS computational biology | 2014

von Haseltine, E. | De Meyer, S. | Dierynck, I. | +9

8

Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir

enthalten in: Virology journal | 2014

von De Meyer, S. | Ghys, A. | Dierynck, I. | +3

9

Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C

enthalten in: Gastroenterology | 2014

von Buti, M. | Agarwal, K. | Horsmans, Y. | +13

10

Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2014

von Picchio, G. | De Meyer, S. | Dierynck, I. | +10